Efficacy of articaine for brachial plexus block: a prospective randomized study
- Authors: Lakhin R.Е.1,2, Tsvetkov V.G.1, Polezhankin E.V.1, Zhirnova E.A.3, Babicheva P.A.1, Kuchina S.N.1
-
Affiliations:
- Kirov Military Medical Academy
- Saratov State Medical University named after V.I. Razumovsky
- Saint Petersburg State University
- Issue: Vol 19, No 2 (2025)
- Pages: 145-153
- Section: Original articles
- URL: https://bakhtiniada.ru/1993-6508/article/view/312951
- DOI: https://doi.org/10.17816/RA642696
- EDN: https://elibrary.ru/MCMFEC
- ID: 312951
Cite item
Abstract
BACKGROUND: Articaine is widely used for infiltration and conduction anesthesia in dentistry; however, few studies have examined its use in regional blocks during limb surgeries.
AIM: The work aimed to compare the effectiveness of regional anesthesia with articaine versus ropivacaine in upper limb surgeries.
METHODS: A single-center, prospective, randomized study was conducted. It included 60 patients (all male), aged 35.2 ± 15.3 years, who underwent upper limb surgery under regional anesthesia. Patients were randomized into two groups: group 1 (n = 30) received 2% articaine, and group 2 (n = 30) received 0.5% ropivacaine. The groups were divided into subgroups (n = 15) based on the approach used: interscalene or axillary. The primary endpoint was the onset of sensory and motor block. Secondary endpoints included block duration and the incidence of adverse effects (nausea/vomiting, arterial hypotension, bradycardia, and dizziness).
RESULTS: When evaluating sensory block characteristics 30 minutes after anesthetic administration, statistically significant differences were observed only in the rate of block onset. In the articaine group, sensory block developed more rapidly with both the interscalene (group 1: 7.0 ± 2.9 min vs group 2: 10.0 ± 3.1 min [p = 0.015]) and axillary approaches (group 1: 8.0 ± 2.1 min vs group 2: 12.0 ± 4.2 min [p = 0.02]). Interscalene block resulted in complete shoulder immobility in 12 (80%) patients in group 1 and 13 (86.7%) in group 2. With axillary block, finger flexion was absent in 8 (53.3%) patients in group 1 and 9 (60%) in group 2 (p = 0.117). The block duration was longer in group 2 than in group 1, both for the interscalene approach (sensory: 12.1 ± 5.4 h vs 3.1 ± 0.5 h [p = 0.001]; motor: 5.3 ± 2.2 h vs 2.2 ± 0.8 h [p = 0.016]) and the axillary approach (sensory: 10.3 ± 3.2 h vs 2.8 ± 0.7 h [p = 0.001]; motor: 4.9 ± 1.4 h vs 1.7 ± 0.4 h [p = 0.02]). For complication rates, hoarseness was more frequently observed in the ropivacaine group (p = 0.03).
CONCLUSION: The quality and intensity of brachial plexus block using articaine is comparable to that of ropivacaine. Articaine block was characterized by a faster onset of sensory anesthesia and a shorter duration of both sensory and motor block compared with ropivacaine. For complication rates, hoarseness occurred less frequently in the articaine group.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Roman Е. Lakhin
Kirov Military Medical Academy; Saratov State Medical University named after V.I. Razumovsky
Author for correspondence.
Email: doctor-lahin@yandex.ru
ORCID iD: 0000-0001-6819-9691
SPIN-code: 7261-9985
MD, Dr. Sci. (Medicine), Professor; аddress
Russian Federation, Saint Petersburg; SaratovVasily G. Tsvetkov
Kirov Military Medical Academy
Email: vasilii_cvetkov@mail.ru
ORCID iD: 0000-0003-4980-597X
SPIN-code: 5316-4617
Russian Federation, Saint Petersburg
Evgeniy V. Polezhankin
Kirov Military Medical Academy
Email: edoktorx@mail.ru
ORCID iD: 0009-0007-6311-1698
MD
Russian Federation, Saint PetersburgEkaterina A. Zhirnova
Saint Petersburg State University
Email: kate-embrace@mail.ru
ORCID iD: 0000-0003-1865-3838
SPIN-code: 1018-3223
MD
Russian Federation, Saint PetersburgPolina A. Babicheva
Kirov Military Medical Academy
Email: polisish30@gmail.com
ORCID iD: 0009-0003-7454-1993
MD
Russian Federation, Saint PetersburgSvetlana N. Kuchina
Kirov Military Medical Academy
Email: svetl.kuchina@mail.ru
ORCID iD: 0000-0001-7893-3183
SPIN-code: 1860-5110
MD
Russian Federation, Saint PetersburgReferences
- Zhang H, Wu J, Miao Y, et al. Determination of the Optimal Volume of 0.5% Ropivacaine in Single-Injection Retroclavicular Brachial Plexus Block for Arthroscopic Shoulder Surgery: A Phase I/II Trial. Anesthesiology. 2025;142(1):155–165. doi: 10.1097/ALN.0000000000005159
- Xuan Q, Pan R, Wang A, et al. The 90% minimum effective volume of 0.5 ropivacaine for ultrasound-guided supraclavicular brachial plexus block: A biased coin up-and-down design. Anaesthesiologie. 2023;72(Suppl 1):39–43. doi: 10.1007/s00101-023-01344-7
- Wu L, Zhang W, Zhang X, et al. Optimal concentration of ropivacaine for brachial plexus blocks in adult patients undergoing upper limb surgeries: a systematic review and meta-analysis. Front Pharmacol. 2023;14:1288697. doi: 10.3389/FPHAR.2023.1288697
- Van Oss GE, Vree TB, Baars AM, et al. Pharmacokinetics, metabolism, and renal excretion of articaine and its metabolite articainic acid in patients after epidural administration. Eur J Anaesthesiol. 1989;6(1):49–56.
- Moller RA, Covino BG. Cardiac electrophysiologic effects of articaine compared with bupivacaine and lidocaine. Anesth Analg. 1993;76(6):1266–1273. doi: 10.1213/00000539-199306000-00014
- Simon MAM, Vree TB, Gielen MJM, et al. Similar motor block effects with different disposition kinetics between lidocaine and (+ or -) articaine in patients undergoing axillary brachial plexus block during day case surgery. Int J Clin Pharmacol Ther. 1999;37(12):598–607.
- Armanious SH, Abdelhameed GA. A Randomized Controlled Trial: Comparison of 4% Articaine versus 0.5% Bupivacaine for Ambulatory Orthopedic Surgery under Supraclavicular Block. Anesthesiol Res Pract. 2020;2020:2194873. doi: 10.1155/2020/2194873
- Ertikin A, Argun G, Mısırlıoğlu M, et al. Comparison Between the Two-Injection Technique and the Four-Injection Technique in Axillary Brachial Plexus Block with Articaine. Turk J Anaesthesiol Reanim. 2017;45(5):289–296. doi: 10.5152/TJAR.2017.16023
- Kilinc L, Cinar S, Turk HS. Prolonged Analgesic Efficacy of Articaine with the Addition of Tramadol in Axillary Brachial Plexus Block. Sisli Etfal Hastan Tip Bul. 2019;53(1):21–26. doi: 10.14744/SEMB.2018.03274
- Karelov AE, Vasilieva GN, Semkichev VA, et al. Articaine using for out-hospital patients with side effects to lidocaine: a pilot study. Russian Journal of Anesthesiology and Reanimatology. 2022;(2):41–46. doi: 10.17116/anaesthesiology202202141 EDN: ZIGMZH
- Bayalieva AZ, Yankovich YN, Mohsin M, Davydova VR. Possibilities of clinical application of articaine. Regional Anesthesia and Acute Pain Management. 2022;16(2):103–114. doi: 10.17816/RA108091 EDN: MOMOFN
- Krainyukov PE, Agafonov DE, Kokorin VV, et al. Influence of the choice of tactics of surgical treatment of victims with battle lesions of the lower limb on their psycho-emotional status. Bulletin of Pirogov National Medical & Surgical Center. 2023;18(4):98–102. doi: 10.25881/20728255_2023_18_4_98 EDN: CZOSCY
- Chulovskaya IG, Egiazaryan K, Shatov AM, Kosmynin VS. The use of articaine for anesthetic support in geriatric patients with degenerative-dystrophic hand and forearm conditions: results of a randomized trial. Surgical practice (Russia). 2023;(3):59–72. doi: 10.38181/2223-2427-2023-3-5 EDN: HSENVI
- Lee R, Kim YM, Choi EM, et al. Effect of warmed ropivacaine solution on onset and duration of axillary block. Korean J Anesthesiol. 2012;62(1):52–56. doi: 10.4097/kjae.2012.62.1.52
- Vasavada K, Jahagirdar V, Rama K, Qavi D. Minimum Effective Volume of 0.75% Ropivacaine for Ultrasound-Guided Axillary Brachial Plexus Block. Cureus. 2020;12(12):e12229.
- Yurtlu DA, Kaya K. Ropivacaine, articaine or combination of ropivacaine and articaine for epidural anesthesia in cesarean section: a randomized, prospective, double-blinded study. Braz J Anesthesiol. 2013;63(1):85–91. doi: 10.1016/j.bjane.2012.03.005
- Fanelli G, Casati A, Garancini P, et al. Nerve stimulator and multiple injection technique for upper and lower limb blockade: failure rate, patient acceptance, and neurologic complications. Study Group on Regional Anesthesia. Anesth Analg. 1999;88(4):847–852. doi: 10.1097/00000539-199904000-00031
- Vester-Andersen T, Husum B, Lindeburg T, et al. Perivascular axillary block IV: blockade following 40, 50 or 60 ml of mepivacaine 1% with adrenaline. Acta Anaesthesiol Scand. 1984;28(1):99–105. doi: 10.1111/j.1399-6576.1984.tb02020.x
- Vadagandla K, Jahagirdar V, Rama K, et al. Minimum Effective Volume of 0.75% Ropivacaine for Ultrasound-Guided Axillary Brachial Plexus Block. Cureus. 2020;12(12):e12229. doi: 10.7759/CUREUS.12229
- Gautier P, Vandepitte C, Ramquet C, et al. The minimum effective anesthetic volume of 0.75% ropivacaine in ultrasound-guided interscalene brachial plexus block. Anesth Analg. 2011;113(4):951–955. doi: 10.1213/ANE.0b013e31822b876f
- Mittal K, Janweja S, Prateek P, et al. Mittal K, Janweja S, Prateek, Sangwan P, Agarwal D, Tak H. The estimation of minimum effective volume of 0.5% ropivacaine in ultrasound-guided interscalene brachial plexus nerve block: A clinical trial. J Anaesthesiol Clin Pharmacol. 2019;35(1):41–46. doi: 10.4103/joacp.JOACP_70_18
Supplementary files
